XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities      
Net loss from operations $ (574,000) $ (4,199,000) $ (24,721,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation, depletion, and amortization 924,000 1,139,000 2,676,000
Amortization of loan fees-interest expenses 20,000 11,000 10,000
Accretion of discount on asset retirement obligation 141,000 143,000 126,000
Impairment   2,805,000 14,526,000
Gain on assets sale of vehicles/equipment (2,000)   (41,000)
Compensation and services paid in stock / stock options 14,000 17,000 12,000
Deferred income tax expense (benefit) (242,000)   7,351,000
Changes in assets and liabilities:      
Restricted cash     386,000
Accounts receivable (118,000) (46,000) 432,000
Inventory and other assets 203,000 (238,000) 198,000
Accounts payable (95,000) (482,000) (58,000)
Accrued liabilities (64,000) (89,000) (398,000)
Settlement on asset retirement obligations (53,000) (73,000) (17,000)
Net cash provided by (used in) operating activities 154,000 (1,012,000) 482,000
Investing activities      
Additions to oil and gas properties (169,000) (397,000) (570,000)
Sale of oil and gas properties 7,000 44,000  
Additions to Manufactured Methane facilities   (47,000)  
Additions to other property & equipment (17,000) (5,000) (1,000)
Proceeds from sale of other property & equipment   4,000 30,000
Net cash used in investing activities (179,000) (401,000) (541,000)
Financing activities      
Proceeds from rights offering 2,699,000    
Issuance cost of rights offering (102,000)    
Proceeds from borrowings 400,000 3,850,000 4,300,000
Repayment of borrowings (2,854,000) (2,376,000) (4,234,000)
Loan fees (9,000) (25,000) (2,000)
Net cash provided by financing activities 134,000 1,449,000 64,000
Net change in cash and cash equivalents 109,000 36,000 5,000
Cash and cash equivalents, beginning of period 76,000 40,000 35,000
Cash and cash equivalents, end of period 185,000 76,000 40,000
Supplemental cash flow information:      
Cash interest payments 33,000 91,000 70,000
Supplemental non-cash investing and financing activities:      
Financed company vehicles 81,000 23,000 140,000
Cost of stock issuance in rights offering (140,000)    
Asset retirement obligations incurred 1,000 2,000  
Revisions in estimated liabilities $ 138,000 (210,000) $ 112,000
Capital expenditures included in accounts payable and accrued liabilities   $ 7,000